Regional differences in the management and outcome of kidney transplantation in patients with human immunodeficiency virus infection: A 3‐year retrospective cohort study

Background In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries concentrate 90% of the people living with HIV, but their experience is underreported. Regional differences may affect outcomes. Objec...

Full description

Saved in:
Bibliographic Details
Published inTransplant infectious disease Vol. 19; no. 4
Main Authors Cristelli, Marina P., Cofán, Federico, Tedesco‐Silva, Helio, Trullàs, Joan Carles, Santos, Daniel Wagner C. L., Manzardo, Christian, Agüero, Fernando, Moreno, Asunción, Oppenheimer, Federico, Diekmann, Fritz, Medina‐Pestana, Jose O., Miro, Jose Maria, Alcaraz, A., Ambrosioni, J., Bodro, M., Blanco, J.L., Brunet, M., Garcia, F., Paredes, D., Esforzado, N., Marcos, M.A., Mallolas, J., Martinez, E., Mosquera, M.D., Musquera, M., Peri, L., Revuelta, I., Ricart, M.J., Soy, D., Torregrosa, J.V., Tuset, M.
Format Journal Article
LanguageEnglish
Published Denmark Wiley Subscription Services, Inc 01.08.2017
Subjects
Online AccessGet full text
ISSN1398-2273
1399-3062
1399-3062
DOI10.1111/tid.12724

Cover

Abstract Background In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries concentrate 90% of the people living with HIV, but their experience is underreported. Regional differences may affect outcomes. Objectives We compared the 3‐year outcomes of patients with HIV infection receiving a KT in two different countries, in terms of incomes and development. Methods This was an observational, retrospective, double‐center study, including all HIV‐infected patients >18 years old undergoing KT. Results Between 2005 and 2015, 54 KTs were performed (39 in a Brazilian center, and 15 in a Spanish center). Brazilians had less hepatitis C virus co‐infection (5% vs 27%, P=.024). Median cold ischemia time was higher in Brazil (25 vs 18 hours, P=.001). Biopsy‐proven acute rejection (AR) was higher in Brazil (33% vs 13%, P=.187), as were the number of AR episodes (22 vs 4, P=.063). Patient survival at 3 years was 91.3% in Brazil and 100% in Spain; P=.663. All three cases of death in Brazil were a result of bacterial infections within the first year post transplant. At 3 years, survival free from immunosuppressive changes was lower in Brazil (56% vs 90.9%, P=.036). Raltegravir‐based treatment to avoid interaction with calcineurin inhibitor was more prevalent in Spain (80% vs 3%; P<.001). HIV infection remained under control in all patients, with undetectable viral load and no opportunistic infections. Conclusion Important regional differences exist in the demographics and management of immunosuppression and antiretroviral therapy. These details may influence AR and infectious complications. Non‐AIDS infections leading to early mortality in Brazil deserve special attention.
AbstractList In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries concentrate 90% of the people living with HIV, but their experience is underreported. Regional differences may affect outcomes. We compared the 3-year outcomes of patients with HIV infection receiving a KT in two different countries, in terms of incomes and development. This was an observational, retrospective, double-center study, including all HIV-infected patients >18 years old undergoing KT. Between 2005 and 2015, 54 KTs were performed (39 in a Brazilian center, and 15 in a Spanish center). Brazilians had less hepatitis C virus co-infection (5% vs 27%, P=.024). Median cold ischemia time was higher in Brazil (25 vs 18 hours, P=.001). Biopsy-proven acute rejection (AR) was higher in Brazil (33% vs 13%, P=.187), as were the number of AR episodes (22 vs 4, P=.063). Patient survival at 3 years was 91.3% in Brazil and 100% in Spain; P=.663. All three cases of death in Brazil were a result of bacterial infections within the first year post transplant. At 3 years, survival free from immunosuppressive changes was lower in Brazil (56% vs 90.9%, P=.036). Raltegravir-based treatment to avoid interaction with calcineurin inhibitor was more prevalent in Spain (80% vs 3%; P<.001). HIV infection remained under control in all patients, with undetectable viral load and no opportunistic infections. Important regional differences exist in the demographics and management of immunosuppression and antiretroviral therapy. These details may influence AR and infectious complications. Non-AIDS infections leading to early mortality in Brazil deserve special attention.
Background In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries concentrate 90% of the people living with HIV, but their experience is underreported. Regional differences may affect outcomes. Objectives We compared the 3-year outcomes of patients with HIV infection receiving a KT in two different countries, in terms of incomes and development. Methods This was an observational, retrospective, double-center study, including all HIV-infected patients >18 years old undergoing KT. Results Between 2005 and 2015, 54 KTs were performed (39 in a Brazilian center, and 15 in a Spanish center). Brazilians had less hepatitis C virus co-infection (5% vs 27%, P=.024). Median cold ischemia time was higher in Brazil (25 vs 18 hours, P=.001). Biopsy-proven acute rejection (AR) was higher in Brazil (33% vs 13%, P=.187), as were the number of AR episodes (22 vs 4, P=.063). Patient survival at 3 years was 91.3% in Brazil and 100% in Spain; P=.663. All three cases of death in Brazil were a result of bacterial infections within the first year post transplant. At 3 years, survival free from immunosuppressive changes was lower in Brazil (56% vs 90.9%, P=.036). Raltegravir-based treatment to avoid interaction with calcineurin inhibitor was more prevalent in Spain (80% vs 3%; P<.001). HIV infection remained under control in all patients, with undetectable viral load and no opportunistic infections. Conclusion Important regional differences exist in the demographics and management of immunosuppression and antiretroviral therapy. These details may influence AR and infectious complications. Non-AIDS infections leading to early mortality in Brazil deserve special attention.
In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries concentrate 90% of the people living with HIV, but their experience is underreported. Regional differences may affect outcomes.BACKGROUNDIn the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries concentrate 90% of the people living with HIV, but their experience is underreported. Regional differences may affect outcomes.We compared the 3-year outcomes of patients with HIV infection receiving a KT in two different countries, in terms of incomes and development.OBJECTIVESWe compared the 3-year outcomes of patients with HIV infection receiving a KT in two different countries, in terms of incomes and development.This was an observational, retrospective, double-center study, including all HIV-infected patients >18 years old undergoing KT.METHODSThis was an observational, retrospective, double-center study, including all HIV-infected patients >18 years old undergoing KT.Between 2005 and 2015, 54 KTs were performed (39 in a Brazilian center, and 15 in a Spanish center). Brazilians had less hepatitis C virus co-infection (5% vs 27%, P=.024). Median cold ischemia time was higher in Brazil (25 vs 18 hours, P=.001). Biopsy-proven acute rejection (AR) was higher in Brazil (33% vs 13%, P=.187), as were the number of AR episodes (22 vs 4, P=.063). Patient survival at 3 years was 91.3% in Brazil and 100% in Spain; P=.663. All three cases of death in Brazil were a result of bacterial infections within the first year post transplant. At 3 years, survival free from immunosuppressive changes was lower in Brazil (56% vs 90.9%, P=.036). Raltegravir-based treatment to avoid interaction with calcineurin inhibitor was more prevalent in Spain (80% vs 3%; P<.001). HIV infection remained under control in all patients, with undetectable viral load and no opportunistic infections.RESULTSBetween 2005 and 2015, 54 KTs were performed (39 in a Brazilian center, and 15 in a Spanish center). Brazilians had less hepatitis C virus co-infection (5% vs 27%, P=.024). Median cold ischemia time was higher in Brazil (25 vs 18 hours, P=.001). Biopsy-proven acute rejection (AR) was higher in Brazil (33% vs 13%, P=.187), as were the number of AR episodes (22 vs 4, P=.063). Patient survival at 3 years was 91.3% in Brazil and 100% in Spain; P=.663. All three cases of death in Brazil were a result of bacterial infections within the first year post transplant. At 3 years, survival free from immunosuppressive changes was lower in Brazil (56% vs 90.9%, P=.036). Raltegravir-based treatment to avoid interaction with calcineurin inhibitor was more prevalent in Spain (80% vs 3%; P<.001). HIV infection remained under control in all patients, with undetectable viral load and no opportunistic infections.Important regional differences exist in the demographics and management of immunosuppression and antiretroviral therapy. These details may influence AR and infectious complications. Non-AIDS infections leading to early mortality in Brazil deserve special attention.CONCLUSIONImportant regional differences exist in the demographics and management of immunosuppression and antiretroviral therapy. These details may influence AR and infectious complications. Non-AIDS infections leading to early mortality in Brazil deserve special attention.
Background In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries concentrate 90% of the people living with HIV, but their experience is underreported. Regional differences may affect outcomes. Objectives We compared the 3‐year outcomes of patients with HIV infection receiving a KT in two different countries, in terms of incomes and development. Methods This was an observational, retrospective, double‐center study, including all HIV‐infected patients >18 years old undergoing KT. Results Between 2005 and 2015, 54 KTs were performed (39 in a Brazilian center, and 15 in a Spanish center). Brazilians had less hepatitis C virus co‐infection (5% vs 27%, P=.024). Median cold ischemia time was higher in Brazil (25 vs 18 hours, P=.001). Biopsy‐proven acute rejection (AR) was higher in Brazil (33% vs 13%, P=.187), as were the number of AR episodes (22 vs 4, P=.063). Patient survival at 3 years was 91.3% in Brazil and 100% in Spain; P=.663. All three cases of death in Brazil were a result of bacterial infections within the first year post transplant. At 3 years, survival free from immunosuppressive changes was lower in Brazil (56% vs 90.9%, P=.036). Raltegravir‐based treatment to avoid interaction with calcineurin inhibitor was more prevalent in Spain (80% vs 3%; P<.001). HIV infection remained under control in all patients, with undetectable viral load and no opportunistic infections. Conclusion Important regional differences exist in the demographics and management of immunosuppression and antiretroviral therapy. These details may influence AR and infectious complications. Non‐AIDS infections leading to early mortality in Brazil deserve special attention.
Author Agüero, Fernando
Musquera, M.
Cristelli, Marina P.
Marcos, M.A.
Revuelta, I.
Medina‐Pestana, Jose O.
Alcaraz, A.
Ricart, M.J.
Torregrosa, J.V.
Tuset, M.
Cofán, Federico
Soy, D.
Diekmann, Fritz
Blanco, J.L.
Miro, Jose Maria
Paredes, D.
Oppenheimer, Federico
Bodro, M.
Manzardo, Christian
Mosquera, M.D.
Trullàs, Joan Carles
Garcia, F.
Esforzado, N.
Santos, Daniel Wagner C. L.
Ambrosioni, J.
Tedesco‐Silva, Helio
Moreno, Asunción
Martinez, E.
Mallolas, J.
Peri, L.
Brunet, M.
Author_xml – sequence: 1
  givenname: Marina P.
  orcidid: 0000-0002-2813-0400
  surname: Cristelli
  fullname: Cristelli, Marina P.
  organization: UNIFESP
– sequence: 2
  givenname: Federico
  surname: Cofán
  fullname: Cofán, Federico
  organization: University of Barcelona
– sequence: 3
  givenname: Helio
  surname: Tedesco‐Silva
  fullname: Tedesco‐Silva, Helio
  organization: UNIFESP
– sequence: 4
  givenname: Joan Carles
  surname: Trullàs
  fullname: Trullàs, Joan Carles
  organization: University of Girona
– sequence: 5
  givenname: Daniel Wagner C. L.
  surname: Santos
  fullname: Santos, Daniel Wagner C. L.
  organization: UNIFESP
– sequence: 6
  givenname: Christian
  surname: Manzardo
  fullname: Manzardo, Christian
  organization: University of Barcelona
– sequence: 7
  givenname: Fernando
  surname: Agüero
  fullname: Agüero, Fernando
  organization: University of Barcelona
– sequence: 8
  givenname: Asunción
  surname: Moreno
  fullname: Moreno, Asunción
  organization: University of Barcelona
– sequence: 9
  givenname: Federico
  surname: Oppenheimer
  fullname: Oppenheimer, Federico
  organization: University of Barcelona
– sequence: 10
  givenname: Fritz
  surname: Diekmann
  fullname: Diekmann, Fritz
  organization: University of Barcelona
– sequence: 11
  givenname: Jose O.
  surname: Medina‐Pestana
  fullname: Medina‐Pestana, Jose O.
  organization: UNIFESP
– sequence: 12
  givenname: Jose Maria
  surname: Miro
  fullname: Miro, Jose Maria
  email: jmmiro@ub.edu
  organization: University of Barcelona
– sequence: 14
  givenname: A.
  surname: Alcaraz
  fullname: Alcaraz, A.
– sequence: 15
  givenname: J.
  surname: Ambrosioni
  fullname: Ambrosioni, J.
– sequence: 16
  givenname: M.
  surname: Bodro
  fullname: Bodro, M.
– sequence: 17
  givenname: J.L.
  surname: Blanco
  fullname: Blanco, J.L.
– sequence: 18
  givenname: M.
  surname: Brunet
  fullname: Brunet, M.
– sequence: 19
  givenname: F.
  surname: Garcia
  fullname: Garcia, F.
– sequence: 20
  givenname: D.
  surname: Paredes
  fullname: Paredes, D.
– sequence: 21
  givenname: N.
  surname: Esforzado
  fullname: Esforzado, N.
– sequence: 22
  givenname: M.A.
  surname: Marcos
  fullname: Marcos, M.A.
– sequence: 23
  givenname: J.
  surname: Mallolas
  fullname: Mallolas, J.
– sequence: 24
  givenname: E.
  surname: Martinez
  fullname: Martinez, E.
– sequence: 25
  givenname: M.D.
  surname: Mosquera
  fullname: Mosquera, M.D.
– sequence: 26
  givenname: M.
  surname: Musquera
  fullname: Musquera, M.
– sequence: 27
  givenname: L.
  surname: Peri
  fullname: Peri, L.
– sequence: 28
  givenname: I.
  surname: Revuelta
  fullname: Revuelta, I.
– sequence: 29
  givenname: M.J.
  surname: Ricart
  fullname: Ricart, M.J.
– sequence: 30
  givenname: D.
  surname: Soy
  fullname: Soy, D.
– sequence: 31
  givenname: J.V.
  surname: Torregrosa
  fullname: Torregrosa, J.V.
– sequence: 32
  givenname: M.
  surname: Tuset
  fullname: Tuset, M.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28508573$$D View this record in MEDLINE/PubMed
BookMark eNp9kctu1jAQhS1URC-w4AWQJTawSOtbLmZXFWgrVUJCZR05zri_S2IH22mVXR-h78Fb8SQ4_QuLSuCNR5rvnNHM2Uc7zjtA6DUlhzS_o2T7Q8pqJp6hPcqlLDip2M5D3RSM1XwX7cd4TQitpZAv0C5rStKUNd9DP7_ClfVODbi3xkAApyFi63DaAB6VU1cwgktYuR77OWk_AvYGf7e9gwWnoFycBuWSStll1U25yoKIb23a4M2cPbAdx9n5HozVuacXfGPDvE4xoFfdB3yM-a-7-wVUwAFS8HFaOzeAtd_4kHBMc7-8RM-NGiK8evwP0LfPny5PzoqLL6fnJ8cXheYlFwVlomnAEFMBU1Ap0qm6kqA7I4VSgnYgJReGkV6UhMmyIkJVnSaacuhr0vED9G7rOwX_Y4aY2tFGDUPeE_wcW9pIKUhVVTyjb5-g134O-ZyZkqwsaUNrkqk3j9TcjdC3U7CjCkv7J4YMvN8COq8eA5i_CCXtGnGbI24fIs7s0RNW2-35cxp2-J_i1g6w_Nu6vTz_uFX8BgXyvAM
CitedBy_id crossref_primary_10_1186_s12981_019_0253_z
crossref_primary_10_1007_s11904_019_00440_x
crossref_primary_10_1186_s12879_024_10026_7
crossref_primary_10_1111_tid_13511
Cites_doi 10.1681/ASN.2014070726
10.1089/aid.2007.0015
10.1093/cid/ciu617
10.7326/0003-4819-150-9-200905050-00006
10.5935/0101-2800.20120029
10.1093/ndt/gfs287
10.1111/tid.12592
10.1097/QAI.0000000000000291
10.1002/bjs.6607
10.1056/NEJMoa1408896
10.1111/ajt.13840
10.1056/NEJMc0900837
10.1111/j.1600-6143.2008.02159.x
10.1038/ki.2010.545
10.1016/j.transproceed.2009.04.013
10.1111/j.1600-6143.2010.03258.x
10.5123/S1679-49742012000300013
10.1016/S1473-3099(15)00056-0
10.1097/TP.0000000000000879
10.1097/TP.0b013e31829df29d
10.1038/ki.2015.74
10.1111/j.1432-2277.2010.01204.x
10.5935/0101-2800.20140049
10.1056/NEJMoa1001197
10.1111/j.1600-6143.2009.02684.x
10.1111/j.1600-6143.2006.01238.x
10.1093/ndt/gfq592
10.1681/ASN.2013050564
10.1681/ASN.2014121234
10.5935/0101-2800.20130048
10.1016/S0140-6736(13)61809-7
10.1097/01.TP.0000436905.54640.8c
10.1590/S0101-28002011000400014
ContentType Journal Article
Contributor Mosquera, M D
Soy, D
Tuset, M
Alcaraz, A
Ambrosioni, J
Paredes, D
Esforzado, N
Marcos, M A
Martinez, E
Torregrosa, J V
Peri, L
Blanco, J L
Revuelta, I
Ricart, M J
Mallolas, J
Musquera, M
Garcia, F
Bodro, M
Brunet, M
Contributor_xml – sequence: 1
  givenname: A
  surname: Alcaraz
  fullname: Alcaraz, A
– sequence: 2
  givenname: J
  surname: Ambrosioni
  fullname: Ambrosioni, J
– sequence: 3
  givenname: M
  surname: Bodro
  fullname: Bodro, M
– sequence: 4
  givenname: J L
  surname: Blanco
  fullname: Blanco, J L
– sequence: 5
  givenname: M
  surname: Brunet
  fullname: Brunet, M
– sequence: 6
  givenname: F
  surname: Garcia
  fullname: Garcia, F
– sequence: 7
  givenname: D
  surname: Paredes
  fullname: Paredes, D
– sequence: 8
  givenname: N
  surname: Esforzado
  fullname: Esforzado, N
– sequence: 9
  givenname: M A
  surname: Marcos
  fullname: Marcos, M A
– sequence: 10
  givenname: J
  surname: Mallolas
  fullname: Mallolas, J
– sequence: 11
  givenname: E
  surname: Martinez
  fullname: Martinez, E
– sequence: 12
  givenname: M D
  surname: Mosquera
  fullname: Mosquera, M D
– sequence: 13
  givenname: M
  surname: Musquera
  fullname: Musquera, M
– sequence: 14
  givenname: L
  surname: Peri
  fullname: Peri, L
– sequence: 15
  givenname: I
  surname: Revuelta
  fullname: Revuelta, I
– sequence: 16
  givenname: M J
  surname: Ricart
  fullname: Ricart, M J
– sequence: 17
  givenname: D
  surname: Soy
  fullname: Soy, D
– sequence: 18
  givenname: J V
  surname: Torregrosa
  fullname: Torregrosa, J V
– sequence: 19
  givenname: M
  surname: Tuset
  fullname: Tuset, M
Copyright 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
2017 Wiley Periodicals, Inc.
Copyright_xml – notice: 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
– notice: 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
– notice: 2017 Wiley Periodicals, Inc.
CorporateAuthor the Sao Paulo‐Barcelona Renal Transplant in HIV Investigators
Sao Paulo-Barcelona Renal Transplant in HIV Investigators
CorporateAuthor_xml – name: the Sao Paulo‐Barcelona Renal Transplant in HIV Investigators
– name: Sao Paulo-Barcelona Renal Transplant in HIV Investigators
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7U9
8FD
FR3
H94
K9.
M7N
P64
7X8
DOI 10.1111/tid.12724
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Virology and AIDS Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Biotechnology Research Abstracts
Technology Research Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
Virology and AIDS Abstracts
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1399-3062
EndPage n/a
ExternalDocumentID 28508573
10_1111_tid_12724
TID12724
Genre article
Multicenter Study
Journal Article
Observational Study
GeographicLocations Brazil
Spain
GeographicLocations_xml – name: Spain
– name: Brazil
GrantInformation_xml – fundername: RETIC, Red de Sida
  funderid: #24‐0858‐09; RD12/0017/0001
– fundername: Spanish Foundation for AIDS Research and Prevention (FIPSE), Madrid (Spain)
  funderid: #24‐0858‐09; RD12/0017/0001
– fundername: FEDER
– fundername: Departament de Salut de la Generalitat de Catalunya
– fundername: Ministerio de Economía y Competitividad, Madrid (Spain)
  funderid: INT15/00168
– fundername: Instituto de Salud Carlos III, Madrid, Spain
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1OC
29Q
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAKAS
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
AEFGJ
AEGXH
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHMBA
AIACR
AIAGR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
XG1
YFH
YUY
ZZTAW
~IA
~WT
AAHHS
AAYXX
ACCFJ
AEEZP
AEQDE
AIWBW
AJBDE
CITATION
AEUQT
AFPWT
CGR
CUY
CVF
ECM
EIF
NPM
WRC
7QO
7U9
8FD
FR3
H94
K9.
M7N
P64
7X8
ID FETCH-LOGICAL-c3534-12488ef0f6e2ae6a0ba769ecbf94aa41be9934f20d450295604a6bc0c13ed70b3
IEDL.DBID DR2
ISSN 1398-2273
1399-3062
IngestDate Fri Jul 11 00:44:42 EDT 2025
Sun Jul 13 03:31:39 EDT 2025
Wed Feb 19 02:44:20 EST 2025
Tue Jul 01 01:27:16 EDT 2025
Thu Apr 24 23:04:00 EDT 2025
Sun Sep 21 06:19:21 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords regional differences
patient survival
acute rejection
antiretroviral therapy
kidney transplantation
Brazil
graft survival
HIV infection
Spain
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3534-12488ef0f6e2ae6a0ba769ecbf94aa41be9934f20d450295604a6bc0c13ed70b3
Notes Funding information
The study was partially funded by the Spanish Foundation for AIDS Research and Prevention (FIPSE), Madrid (Spain) grant #24‐0858‐09 and by the RETIC, Red de Sida RD12/0017/0001, FEDER, Instituto de Salud Carlos III, Madrid, Spain. J.M.M. received a personal intensification research grant #INT15/00168 during 2016 from the Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Madrid (Spain), and a personal 80:20 research grant from the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain during 2017‐19. C.M. received a personal post‐doctoral research grant (Pla Estratègic de Recerca i Innovació en Salut ‐PERIS‐ 2016/2020) from the ‘Departament de Salut de la Generalitat de Catalunya’, Barcelona, Catalonia, Spain during 2017‐2020.
1
See Appendix
.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-2813-0400
PMID 28508573
PQID 1925518170
PQPubID 1096379
PageCount 9
ParticipantIDs proquest_miscellaneous_1899406663
proquest_journals_1925518170
pubmed_primary_28508573
crossref_primary_10_1111_tid_12724
crossref_citationtrail_10_1111_tid_12724
wiley_primary_10_1111_tid_12724_TID12724
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 2017
2017-08-00
2017-Aug
20170801
PublicationDateYYYYMMDD 2017-08-01
PublicationDate_xml – month: 08
  year: 2017
  text: August 2017
PublicationDecade 2010
PublicationPlace Denmark
PublicationPlace_xml – name: Denmark
– name: Malden
PublicationTitle Transplant infectious disease
PublicationTitleAlternate Transpl Infect Dis
PublicationYear 2017
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2015; 15
2010; 10
2009; 41
2013; 28
2012
2010; 363
2011; 33
2016; 100
2014; 25
2010; 362
2008; 8
2006; 6
2011; 79
2009; 150
2013; 382
2016; 18
2012; 34
2016; 16
2014; 67
2015; 372
2015; 26
2009; 96
2013; 35
2015; 88
2006; 26
2013; 96
2014; 59
2009; 9
2014; 36
2011; 24
2015
2011; 26
2013
2007; 23
2014; 34
2012; 21
2014; 97
e_1_2_6_32_1
e_1_2_6_10_1
e_1_2_6_31_1
e_1_2_6_30_1
e_1_2_6_19_1
Mazuecos A (e_1_2_6_13_1) 2006; 26
e_1_2_6_36_1
e_1_2_6_14_1
e_1_2_6_35_1
e_1_2_6_34_1
e_1_2_6_12_1
e_1_2_6_33_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_39_1
e_1_2_6_15_1
e_1_2_6_38_1
e_1_2_6_16_1
e_1_2_6_37_1
e_1_2_6_21_1
e_1_2_6_20_1
e_1_2_6_9_1
e_1_2_6_8_1
González‐García J (e_1_2_6_29_1) 2012
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
Panel de Expertos del Grupo de Estudio de SIDA (GESIDA), la Sociedad Española de Nefrología (S.E.N.) y la Sociedad Española de Bioquímica Clínica y Patología Molecular (SEQC) (e_1_2_6_11_1) 2014; 34
e_1_2_6_6_1
e_1_2_6_25_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_28_1
e_1_2_6_27_1
e_1_2_6_26_1
References_xml – volume: 18
  start-page: 730
  year: 2016
  end-page: 740
  article-title: Renal transplantation in human immunodeficiency virus‐infected recipients: A case‐control study from the Brazilian experience
  publication-title: Transpl Infect Dis
– volume: 41
  start-page: 3667
  year: 2009
  end-page: 3670
  article-title: Risk factors associated with graft loss and patient survival after kidney transplantation
  publication-title: Transplant Proc
– volume: 88
  start-page: 341
  year: 2015
  end-page: 349
  article-title: Superior outcomes in HIV‐positive kidney transplant patients compared with HCV‐infected or HIV/HCV‐coinfected recipients
  publication-title: Kidney Int
– volume: 96
  start-page: 685
  year: 2009
  end-page: 691
  article-title: Case‐matched comparison of long‐term results of non‐heart beating and heart‐beating donor renal transplants
  publication-title: Br J Surg
– volume: 23
  start-page: 1161
  year: 2007
  end-page: 1165
  article-title: Effect of thymoglobulin induction on HIV‐infected renal transplant recipients: Differences between HIV‐positive and HIV‐negative patients
  publication-title: AIDS Res Hum Retroviruses
– volume: 67
  start-page: 177
  year: 2014
  end-page: 180
  article-title: End‐stage kidney disease and kidney transplantation in HIV‐positive patients: An observational cohort study
  publication-title: J Acquir Immune Defic Syndr
– volume: 34
  start-page: 387
  year: 2012
  end-page: 391
  article-title: Kidney transplantation in HIV positive patients: Two case reports from Hospital de Clínicas de Porto Alegre initial experience
  publication-title: J Bras Nefrol
– volume: 26
  start-page: 3114
  year: 2015
  end-page: 3122
  article-title: Adverse outcomes of tacrolimus withdrawal in immune‐quiescent kidney transplant recipients
  publication-title: J Am Soc Nephrol
– volume: 79
  start-page: 825
  year: 2011
  end-page: 842
  article-title: Renal transplantation in HIV‐infected patients: 2010 update
  publication-title: Kidney Int
– volume: 35
  start-page: 289
  year: 2013
  end-page: 298
  article-title: Influence of deceased donor hemodynamic factors in transplant recipients renal function
  publication-title: J Bras Nefrol
– volume: 36
  start-page: 339
  year: 2014
  end-page: 351
  article-title: Risk assessment score in pre‐kidney transplantation: Methodology and the socioeconomic characteristics importance
  publication-title: J Bras Nefrol
– volume: 25
  start-page: 407
  year: 2014
  end-page: 419
  article-title: The kidney as a reservoir for HIV‐1 after renal transplantation
  publication-title: J Am Soc Nephrol
– volume: 10
  start-page: 2263
  year: 2010
  end-page: 2269
  article-title: Renal transplantation in HIV‐infected patients: The Paris experience
  publication-title: Am J Transplant
– volume: 6
  start-page: 753
  year: 2006
  end-page: 760
  article-title: Thymoglobulin‐associated Cd4 T‐cell depletion and infection risk in HIV‐infected renal transplant recipients
  publication-title: Am J Transplant
– volume: 26
  start-page: 113
  year: 2006
  end-page: 120
  article-title: Renal transplantation in HIV‐infected patients in Spain
  publication-title: Nefrología
– volume: 8
  start-page: 753
  year: 2008
  end-page: 760
  article-title: Banff 07 classification of renal allograft pathology: Updates and future directions
  publication-title: Am J Transplant
– volume: 372
  start-page: 613
  year: 2015
  end-page: 620
  article-title: HIV‐positive‐to‐HIV‐positive kidney transplantation‐results at 3 to 5 years
  publication-title: N Engl J Med
– volume: 363
  start-page: 2004
  year: 2010
  end-page: 2014
  article-title: Outcomes of kidney transplantation in HIV‐infected recipients
  publication-title: N Engl J Med
– year: 2012
– volume: 26
  start-page: 2222
  year: 2015
  end-page: 2229
  article-title: A national study of outcomes among HIV‐Infected kidney transplant recipients
  publication-title: J Am Soc Nephrol
– volume: 100
  start-page: 871
  year: 2016
  end-page: 878
  article-title: Impact of tacrolimus compared with cyclosporin on the incidence of acute allograft rejection in human immunodeficiency virus‐positive kidney transplant recipients
  publication-title: Transplantation
– volume: 21
  start-page: 475
  year: 2012
  end-page: 486
  article-title: Co‐infection of hepatitis B or C and human immunodeficiency virus: An exploratory study in the State of São Paulo, Brazil, 2007 to 2010
  publication-title: Epidemiol Serv Saúde
– volume: 28
  start-page: 213
  year: 2013
  end-page: 220
  article-title: Comparison of the long‐term outcomes of kidney transplantation: USA versus Spain
  publication-title: Nephrol Dial Transplant
– volume: 33
  start-page: 472
  year: 2011
  end-page: 484
  article-title: Kidney transplantation in Brazil and its geographic disparity
  publication-title: J Bras Nefrol
– volume: 382
  start-page: 1525
  year: 2013
  end-page: 1533
  article-title: The end of AIDS: HIV infection as a chronic disease
  publication-title: Lancet
– volume: 97
  start-page: 446
  year: 2014
  end-page: 450
  article-title: Immunosuppression regimen and the risk of acute rejection in HIV‐infected kidney transplant recipients
  publication-title: Transplantation
– volume: 26
  start-page: 1401
  year: 2011
  end-page: 1407
  article-title: HIV infection and renal transplantation
  publication-title: Nephrol Dial Transplant
– volume: 150
  start-page: 604
  year: 2009
  end-page: 612
  article-title: A new equation to estimate glomerular filtration rate
  publication-title: Ann Intern Med
– volume: 362
  start-page: 2336
  year: 2010
  end-page: 2337
  article-title: Renal transplantation between HIV‐positive donors and recipients
  publication-title: N Engl J Med
– volume: 16
  start-page: 2368
  year: 2016
  end-page: 2376
  article-title: Induction immunosuppression and clinical outcomes in kidney transplant recipients infected with human immunodeficiency virus
  publication-title: Am J Transplant
– volume: 15
  start-page: 810
  year: 2015
  end-page: 818
  article-title: Future challenges for clinical care of an ageing population infected with HIV: A modelling study
  publication-title: Lancet Infect Dis
– volume: 96
  start-page: 333
  year: 2013
  end-page: 360
  article-title: Updated international consensus guidelines on the management of cytomegalovirus in solid‐organ transplantation
  publication-title: Transplantation
– volume: 59
  start-page: e96
  year: 2014
  end-page: e138
  article-title: Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America
  publication-title: Clin Infect Dis
– volume: 9
  start-page: 1946
  year: 2009
  end-page: 1952
  article-title: Safety and efficacy of raltegravir in HIV‐infected transplant patients cotreated with immunosuppressive drugs
  publication-title: Am J Transplant
– volume: 34
  start-page: S1
  issue: S2
  year: 2014
  end-page: S92
  article-title: Documento de consenso sobre la evaluación y manejo de la afectación renal en pacientes con infección por el VIH
  publication-title: Nefrología
– volume: 24
  start-page: 333
  year: 2011
  end-page: 343
  article-title: Spanish experience as a leading country: What kind of measures were taken?
  publication-title: Transpl Int
– year: 2015
– year: 2013
– ident: e_1_2_6_5_1
  doi: 10.1681/ASN.2014070726
– ident: e_1_2_6_34_1
  doi: 10.1089/aid.2007.0015
– ident: e_1_2_6_10_1
  doi: 10.1093/cid/ciu617
– ident: e_1_2_6_21_1
  doi: 10.7326/0003-4819-150-9-200905050-00006
– ident: e_1_2_6_17_1
  doi: 10.5935/0101-2800.20120029
– ident: e_1_2_6_20_1
  doi: 10.1093/ndt/gfs287
– ident: e_1_2_6_18_1
  doi: 10.1111/tid.12592
– ident: e_1_2_6_6_1
  doi: 10.1097/QAI.0000000000000291
– ident: e_1_2_6_26_1
  doi: 10.1002/bjs.6607
– ident: e_1_2_6_16_1
  doi: 10.1056/NEJMoa1408896
– ident: e_1_2_6_36_1
  doi: 10.1111/ajt.13840
– ident: e_1_2_6_15_1
  doi: 10.1056/NEJMc0900837
– ident: e_1_2_6_22_1
  doi: 10.1111/j.1600-6143.2008.02159.x
– ident: e_1_2_6_12_1
  doi: 10.1038/ki.2010.545
– ident: e_1_2_6_37_1
  doi: 10.1016/j.transproceed.2009.04.013
– ident: e_1_2_6_7_1
  doi: 10.1111/j.1600-6143.2010.03258.x
– volume: 26
  start-page: 113
  year: 2006
  ident: e_1_2_6_13_1
  article-title: Renal transplantation in HIV‐infected patients in Spain
  publication-title: Nefrología
– ident: e_1_2_6_28_1
  doi: 10.5123/S1679-49742012000300013
– ident: e_1_2_6_3_1
  doi: 10.1016/S1473-3099(15)00056-0
– ident: e_1_2_6_32_1
  doi: 10.1097/TP.0000000000000879
– ident: e_1_2_6_23_1
  doi: 10.1097/TP.0b013e31829df29d
– ident: e_1_2_6_9_1
  doi: 10.1038/ki.2015.74
– ident: e_1_2_6_19_1
  doi: 10.1111/j.1432-2277.2010.01204.x
– ident: e_1_2_6_30_1
– ident: e_1_2_6_24_1
– ident: e_1_2_6_39_1
  doi: 10.5935/0101-2800.20140049
– ident: e_1_2_6_4_1
  doi: 10.1056/NEJMoa1001197
– ident: e_1_2_6_14_1
  doi: 10.1111/j.1600-6143.2009.02684.x
– ident: e_1_2_6_35_1
  doi: 10.1111/j.1600-6143.2006.01238.x
– ident: e_1_2_6_8_1
  doi: 10.1093/ndt/gfq592
– volume: 34
  start-page: S1
  issue: 2
  year: 2014
  ident: e_1_2_6_11_1
  article-title: Documento de consenso sobre la evaluación y manejo de la afectación renal en pacientes con infección por el VIH
  publication-title: Nefrología
– ident: e_1_2_6_38_1
  doi: 10.1681/ASN.2013050564
– ident: e_1_2_6_31_1
  doi: 10.1681/ASN.2014121234
– ident: e_1_2_6_27_1
  doi: 10.5935/0101-2800.20130048
– ident: e_1_2_6_2_1
  doi: 10.1016/S0140-6736(13)61809-7
– volume-title: Trends in HCV Infection, Liver Disease Severity, and Specific Treatment Modalities among HIV+ patients: Madrid, Spain
  year: 2012
  ident: e_1_2_6_29_1
– ident: e_1_2_6_33_1
  doi: 10.1097/01.TP.0000436905.54640.8c
– ident: e_1_2_6_25_1
  doi: 10.1590/S0101-28002011000400014
SSID ssj0017949
Score 2.1606207
Snippet Background In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing...
In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries...
Background In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
SubjectTerms Acquired immune deficiency syndrome
acute rejection
Adult
AIDS
Anti-Retroviral Agents - therapeutic use
Antiretroviral agents
Antiretroviral drugs
Antiretroviral therapy
Bacteria
Bacterial infections
Biopsy
Brazil
Calcineurin
Calcineurin Inhibitors - therapeutic use
Cohort analysis
Cohort Studies
Complications
Demographics
Demography
Developing countries
Drug Interactions
Female
Graft rejection
Graft Survival
Hepatitis
Hepatitis C
HIV
HIV infection
HIV Infections - complications
HIV Infections - drug therapy
HIV Infections - virology
Human immunodeficiency virus
Humans
Immunosuppression
Immunosuppressive Agents - therapeutic use
Infections
Ischemia
Kidney Function Tests
Kidney Transplantation
Kidney transplants
LDCs
Male
Middle Aged
patient survival
Patients
Regional differences
Rejection
Retrospective Studies
Spain
Survival
Transplantation
Transplants & implants
Treatment Outcome
Viruses
Title Regional differences in the management and outcome of kidney transplantation in patients with human immunodeficiency virus infection: A 3‐year retrospective cohort study
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Ftid.12724
https://www.ncbi.nlm.nih.gov/pubmed/28508573
https://www.proquest.com/docview/1925518170
https://www.proquest.com/docview/1899406663
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtUwELWqrtjwUHlcKNWAWHSTK8d2khtYVZSqIMGiaqUukCI_UdTWQbkJUlnxCfxH_6pfgsd5iPKQELsoHsuJM2OfcWbOEPIiIHy6KrhNOM_LRGhTJlJwl8jViivmdMYN5ju__5Afnoh3p9npBnk15cIM_BDzgRtaRlyv0cClWv9k5F1tlikrGHKBpjxH3vz9o5k6CvWsjM5WGTQh7NEjqxBG8cw9b-5FvwHMm3g1bjgHd8jH6VGHOJOzZd-ppf76C4vjf77LXXJ7BKKwN2jOPbJh_Ra5OrKf4tkgTIVTwjICtYcAE-FijpQB6Q00fReGsdA4OKuNt5fQRaL0czlkM3nsN9K2rgHPeyEWBIQaU1IaY5G7AhM_4Uvd9jjKEBbmX8Ie8Otv3y-DEUJru7aZ0kEBy_m2HURO3Pvk5ODN8evDZCznkGiecWRHDIuFddTllkmbS6pkkZdWK1cKKUWqbMBKwjFqREYZ-m1C5kpTnXJrCqr4A7LpG28fEWBKOZ2qlCphRMBgKpUu3KCGKpMVOluQ3enDVnrkOseSG-fV5POEGa_ijC_I81n080Dw8Seh7Uk7qtHG11XAxkhnlxZ0QZ7NzcE68ZeL9Lbpg0xwZwW6iHxBHg5aNY_CVhmWFwgtu1E3_j58dfx2P148_nfRJ-QWQwQSYxW3yWbX9vZpwE-d2omG8gOoqxvI
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtUwELVKWcCGh3jdUmBALLrJlWM7yQ1iUwHVLbRdVLdSNyjyKyhqcao0QSorPoH_4K_4EjzOQ5SHhNhFiS0nzox9ZjxzhpDnHuHTRcZtxHmaR0KbPJKCl5FcLLhipU64wXzn_YN0eSTeHifHa-TlmAvT80NMDjfUjLBeo4KjQ_onLW8rM49ZxsQVcjWczyEkOpzIo1DS8mBu5V4W_C498AphHM_U9fJu9BvEvIxYw5azc5O8H1-2jzQ5mXetmuvPv_A4_u_X3CI3BiwK273w3CZr1t0h3w7th-AehLF2il9JoHLgkSJ8nIJlQDoDddf6cSzUJZxUxtkLaANX-qnsE5oc9huYW88BXb4QagJChVkptbFIX4G5n_CpajocpY8Mcy9gG_j3L18vvB5CY9umHjNCASv6Ni0EWty75GjnzerVMhoqOkSaJxwJEv16YUtappZJm0qqZJbmVqsyF1KKWFkPl0TJqBEJZWi6CZkqTXXMrcmo4vfIuqudfUCAKVXqWMVUCSM8DFOxLP0NaqgySaaTGdka_2yhB7pzrLpxWoxmj5_xIsz4jDybmp71HB9_arQ5ikcxqPl54eExMtrFGZ2Rp9Njr6B46iKdrTvfxlu0Aq1EPiP3e7GaRmGLBCsM-CdbQTj-Pnyx2n0dLjb-vekTcm252t8r9nYP3j0k1xkCkhC6uEnW26azjzycatXjoDU_AEMUH-Y
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtUwELVKkRAbCuLRSwsMiEU3uXJsJ7mBVUW5anlUqGqlLpAiP1HUklRpglRWfAL_wV_xJXichygPCbGL4rGcODP2GWfmDCFPPcKni4zbiPM0j4Q2eSQFd5FcLLhiTifcYL7z2_1090i8Ok6OV8jzMRem54eYDtzQMsJ6jQZ-ZtxPRt6WZh6zjIkr5KpI_TaJiOhg4o5CRcuDt5V7VfCb9EArhGE8U9fLm9FvCPMyYA07znKNvB-ftQ80OZl3rZrrz7_QOP7ny9wkNwYkCtu96twiK7a6Tb4d2A_hcBDGyil-HYGyAo8T4eMUKgOyMlB3rR_GQu3gpDSVvYA2MKWfyj6dqcJ-A2_rOeCBL4SKgFBiTkptLJJXYOYnfCqbDkfp48KqZ7AN_PuXrxfeCqGxbVOP-aCA9XybFgIp7h1ytHx5-GI3Guo5RJonHOkR_WphHXWpZdKmkiqZpbnVyuVCShEr68GScIwakVCGjpuQqdJUx9yajCp-l6xWdWXXCTClnI5VTJUwwoMwFUvnb1BDlUkynczI1vhhCz2QnWPNjdNidHr8jBdhxmfkySR61jN8_Eloc9SOYjDy88KDY-SzizM6I4-nZm-e-M9FVrbuvIz3ZwX6iHxG7vVaNY3CFgnWF_AtW0E3_j58cbi3Ey7u_7voI3Lt3c6yeLO3_3qDXGeIRkLc4iZZbZvOPvBYqlUPg838AN3JHpU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Regional+differences+in+the+management+and+outcome+of+kidney+transplantation+in+patients+with+human+immunodeficiency+virus+infection%3A+A+3-year+retrospective+cohort+study&rft.jtitle=Transplant+infectious+disease&rft.au=Cristelli%2C+Marina+P&rft.au=Cof%C3%A1n%2C+Federico&rft.au=Tedesco-Silva%2C+Helio&rft.au=Trull%C3%A0s%2C+Joan+Carles&rft.date=2017-08-01&rft.issn=1399-3062&rft.eissn=1399-3062&rft.volume=19&rft.issue=4&rft_id=info:doi/10.1111%2Ftid.12724&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1398-2273&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1398-2273&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1398-2273&client=summon